NSTD vs. DMAQ, NIVF, JMAC, MCAE, EGOX, NSTC, NSTB, NPAB, MSDL, and OBDE
Should you be buying Northern Star Investment Corp. IV stock or one of its competitors? The main competitors of Northern Star Investment Corp. IV include Deep Medicine Acquisition (DMAQ), NewGenIvf Group (NIVF), Maxpro Capital Acquisition (JMAC), Mountain Crest Acquisition Corp. III (MCAE), Next.e.GO (EGOX), Northern Star Investment Corp. III (NSTC), Northern Star Investment Corp. II (NSTB), New Providence Acquisition Corp. II (NPAB), Morgan Stanley Direct Lending (MSDL), and Blue Owl Capital Co. III (OBDE). These companies are all part of the "holding & other investment offices" industry.
Deep Medicine Acquisition (NASDAQ:DMAQ) and Northern Star Investment Corp. IV (NYSE:NSTD) are both small-cap unclassified companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, media sentiment, profitability, dividends, analyst recommendations, risk, valuation, community ranking and institutional ownership.
18.4% of Deep Medicine Acquisition shares are owned by institutional investors. Comparatively, 2.8% of Northern Star Investment Corp. IV shares are owned by institutional investors. 1.7% of Deep Medicine Acquisition shares are owned by company insiders. Comparatively, 69.5% of Northern Star Investment Corp. IV shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Deep Medicine Acquisition has a beta of 0.02, meaning that its share price is 98% less volatile than the S&P 500. Comparatively, Northern Star Investment Corp. IV has a beta of 0.55, meaning that its share price is 45% less volatile than the S&P 500.
In the previous week, Northern Star Investment Corp. IV's average media sentiment score of 0.00 equaled Deep Medicine Acquisition'saverage media sentiment score.
Deep Medicine Acquisition and Northern Star Investment Corp. IV both received 0 outperform votes by MarketBeat users.
Summary
Northern Star Investment Corp. IV beats Deep Medicine Acquisition on 2 of the 3 factors compared between the two stocks.
Get Northern Star Investment Corp. IV News Delivered to You Automatically
Sign up to receive the latest news and ratings for NSTD and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NSTD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Northern Star Investment Corp. IV Competitors List
Related Companies and Tools
